Revision as of 16:45, 21 October 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified and watched fields - updated 'ChEBI_Ref', 'KEGG_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs)← Previous edit | Revision as of 09:00, 8 December 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEBI_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or bugs)Next edit → | ||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | | Verifiedfields = changed | ||
⚫ | | verifiedrevid = 464383434 | ||
| Watchedfields = changed | |||
⚫ | | verifiedrevid = |
||
| IUPAC_name = dihydro-1''H''-pyrrolizine-3,5(2''H'',6''H'')-dione | | IUPAC_name = dihydro-1''H''-pyrrolizine-3,5(2''H'',6''H'')-dione | ||
| image = Rolziracetam structure.svg | | image = Rolziracetam structure.svg | ||
Line 20: | Line 19: | ||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number_Ref = {{cascite| |
| CAS_number_Ref = {{cascite|changed|??}} | ||
| CAS_number = 18356-28-0 | | CAS_number = 18356-28-0 | ||
| ATC_prefix = none | | ATC_prefix = none | ||
Line 27: | Line 26: | ||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| ChemSpiderID = 64906 | | ChemSpiderID = 64906 | ||
| UNII_Ref = {{fdacite| |
| UNII_Ref = {{fdacite|correct|FDA}} | ||
| UNII = RES9I0LGG5 | | UNII = RES9I0LGG5 | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} | | ChEMBL_Ref = {{ebicite|correct|EBI}} |
Revision as of 09:00, 8 December 2011
Pharmaceutical compoundClinical data | |
---|---|
Other names | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C7H9N2O2 |
Molar mass | 139.152 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects.
See also
References
- Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
Racetams | |
---|---|
Racetams |
|
Phenylpiracetams |
|
Racetam-like |
|
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |